CDA Clinics partners with Bod Australia for patient-based observational study on Medicinal Cannabis
Currently here at CDA Clinics, we have partnered with one of our main Cannabidiol (CBD) producers, Bod, who provide quality pharmaceutical-grade medicine, in an exciting new patient-centred, observational study.
This study will monitor the ongoing health outcomes of patients taking Bod Pharmaceutical Medicinal Cannabis. The results will help Doctors to gain a better understanding of the role of Medicinal Cannabis in treating many different health conditions and help shape further clinical trials.
After the first two bottles reduced pricing will be in place for the duration of the study. Normal clinic consultation costs will still apply.
*Patients will still have to pay for Pharmacy Dispensing and Postage fees on all products.
If you are eligible for Medicinal Cannabis and are interested in participating, please click here for more information.